Loading
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Latest filing published 27 May 2020 for Windtree Therapeutics INC, €14k.
Filing timeline
BuySaleJohn R. Leone
Insider track record
Disclosed buys
6
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
6
Positive at T+90
50%
Median T+90
-10.1%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -75.7%Entry US$327,150.31 · Close at T+365 US$79,650.08
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
John R. Leone: trading record in brief
John R. Leone discloses dealings in 4 companies, chiefly Windtree Therapeutics Inc, Viropharma Inc and Cambrex Corp. Over a trading history stretching from 31 December 2005 to 22 May 2020, the count stands at 20 filings.
Every open-market trade on record is a purchase: 6 purchases worth €40k, and no sale. The amount is not disclosed for 1 filing. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 11 share grants. 2020 to date brings 1 purchase and no sales.
The median purchase comes to €6,473.
The newest entry dates from 27 May 2020: an open-market purchase of €14k, in Windtree Therapeutics Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to John R. Leone
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
2,069 shares@ US$7.25100.0% of flowCommon StockSEC:0001437749-20-011869:0
Canonical exit: 20 Aug 2020 (T+90)
15,000 shares0Common StockSEC:0001437749-18-022664:0
650 sharesCommon StockSEC:0001437749-18-021247:0
4,348 shares0Common StockSEC:0001437749-16-036731:0
16,667 shares0Common StockSEC:0001140361-15-032702:0
50,000 sharesCommon StockSEC:0001140361-15-028594:0
Canonical exit: 20 Oct 2015 (T+90)
4,678 shares0Common StockSEC:0001140361-14-026261:0
17,544 shares0Common StockSEC:0001140361-14-026261:1
11,000 shares@ US$50.00Common StockSEC:0001127602-14-003258:0
4,734 shares0Common StockSEC:0001140361-13-025182:0
4,500 shares0Common StockSEC:0001127602-13-007777:0
3,000 shares@ US$2.88Common StockSEC:0001140361-13-008349:0
Canonical exit: 20 May 2013 (T+90)
4,500 shares0Common StockSEC:0001127602-12-008366:0
300 shares0Common StockSEC:0001181431-08-038738:0
600 shares0Common StockSEC:0001181431-07-074429:0
1,684 shares@ US$12.25Common StockSEC:0001181431-06-052263:0
Canonical exit: 7 Dec 2006 (T+90)
100 shares@ US$12.27Common StockSEC:0001181431-06-052263:1
Canonical exit: 7 Dec 2006 (T+90)
216 shares@ US$12.28Common StockSEC:0001181431-06-052263:2
Canonical exit: 7 Dec 2006 (T+90)
191 shares0Common StockSEC:0000820081-06-000010:0
8,194 shares0Common StockSEC:0000820081-06-000010:1
20 of 20 declarations
